European Archives - Page 1278 of 1452 - European Medical Journal

Awardees of Global Health Research Fund Will Tackle Disease and Infection Around the World

THE FIRST PHASE of awards for the £1.5 billion Global Challenges Research Fund (GCRF) has been announced with a focus on funding projects that will…

Depression in Cancer Patients Leads to Worse Treatment Outcomes

DEPRESSION can lead to a poorer prognosis in cancer patients as a result of the decreased amounts of brain-derived neurotrophic factor (BDNF) in their…

RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT® for Migraines with Pharmatronic Co. In South Korea

Israel, December 14, 2016 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (TASE: RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily…

Bluebird Bio and Apceth Biopharma Establish Commercial Drug Product Manufacturing Agreement

USA and Germany, December 15, 2016 – bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene…

First Data on Rare Sarcomas in Asian Patients Presented at ESMO Asia in Singapore

Lugano-Singapore, December 17, 2016 – The first data on rare sarcomas in Asian patients is presented in three studies today at the ESMO Asia 2016…

New Autoimmune Mutation Found in Enteritis Pathogenesis

NOVEL immunotherapy has successfully ameliorated the symptoms of autoimmune enteritis following the discovery of a genetic mutation within an immune…

Discovery Could Lead to New Treatments for Parkinson’s Disease

A BIOLOGICAL link has been discovered between the gut microbiome and Parkinson’s disease (PD), potentially leading to the development of new…

EMJ

EMJ Weekly News Round-Up: 12th December

Keeping you up to date with the latest news, summarising a selection of stories from us here at EMJ and from across the web.

Prognostic Models Predict Survival in Cancer Patients Receiving Palliative Care

THE FINDINGS of a new study have identified a group of prognostic models with a good ability to predict survival in cancer patients receiving…

RedHill Biopharma Announces Positive and Unanimous DSMB Recommendation for Continuation of Phase III Study with RHB-104 for Crohn’s Disease

Israel, December 13, 2016 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (TASE: RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily…